{"gao_id": "GAO-20-689", "published": "2020-09-23T12:00:00Z", "released": "2020-09-23T08:00:00Z", "summary": "Three FDA regulatory centers help ensure the safety, security, and effectiveness of medical products. These centers had $200 million in property-related expenses in FY 2019. We found that the centers did not consistently collect, analyze, and verify the accuracy of information needed to manage personal property, such as scientific and laboratory equipment and office furniture. Effective management of property can help ensure sound decision-making and...", "title": "Federal Property: Formal Policies Could Enhance FDA's Property Management Efforts", "topics": ["Personal property", "Federal property", "Agency evaluations", "Asset management", "Property management", "User fees", "Government Operations", "Federal property management", "Equipment maintenance", "Prescription drugs", "Real property"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-689", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-689-highlights.pdf"}, {"title": "Full Report (51 pages)", "url": "https://www.gao.gov/assets/gao-20-689.pdf"}, {"title": "Accessible PDF (66 pages)", "url": "https://www.gao.gov/assets/710/709935.pdf"}]}